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clinics. It is to be hoped that referrals to our tertiary
hospitals are more appropriate now. At two of the clinics we
developed a system of writing our notes on a standard form
and made two carbon copies, one for the patient's doctor
and the other for the clinic's records. We aim to implement
this duplicate report system at all three clinics, as such
systems facilitate improvement in care. 17
To conclude, the introduction of the decentralised
outreach clinics forms part of the growing trend towards
'medical schools without walls'.'· Now that we have some
basic information about the clinics we aim to institute
ongoing medical audit. This may include audit of the
management of certain conditions. The clinics seem to have
fulfilled all initial expectations. The study demonstrates that
specialists can greatly reduce health expenditure, both for
patients and the State, and spread the costs more evenly by
commuting to outreach clinics. At the same time such a
strategy addresses the need for services at a level closest to
the people. The non-quantifiable benefits, such as training of
staff in the periphery, as well as patient satisfaction," are
equally important.
We would like to thank Professor Louis Goedhals of the
Department of Oncotherapy who allowed us to share the
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the hospitals as well as the laboratories of the SAIMR provided
a reliable service. Sienie Jankowitz and Johanna Viljoen kindly
drew the map. From the Centre for Health Systems Research,
University of the Free State, Professor Dingie van Rensburg
gave useful criticism, while Ms Tankiso Rammile gave secretarial
help. Or Beth Engelbrecht and Mrs T Germishuizen of the Free
State Department of Health provided vital information.
REFERENCES
1. Krige os. DemographIC Profile of the Free State. Bloemfonteln: Department of
Urban and Regional Planning, University of the Orange Free State, 1995; 1-66.
2. Department of Health. White paper for the transformation of the health system in
South Africa. Government Gazette 1997; 382(17910): 1-223.
3. Centre for Health Systems Research and Development. Health Care In the Free
State: Implications for Planning. Durban: Health Systems TrlJst and Department of
Health, 1961; 1-127.
4. Fourie J. Gagiano CA. 'n Moderne psigiatriese gemeenskapsdiens in die Oranje-
Vrystaal. S AIr Med J 1988; 73: 427-429.
5. Gagiano CA. Development of a psychiatric community service in the Orange Free
State. Republic of South Africa. In: Stefanis CN, Soldatos CA, Rabavlias AD, eds.
Psychiatry: A World Perspective. Amsterdam: Excerpta Medica, 1990; 530-532.
6. Denham JW. How do we bnng an acceptable level of radiotherapy services to a
dispersed population? Australas Radio/1995; 39: 171-173.
7. Rusthoven JJ, Wodinsky H, Osoba D. Canadian cancer care: organizational
models. Ann Intern Med 1986; 105: 932-936.
8. Shaw CD. The background. In: SmIth R, ed. Audit in Action. London: BMJ
Publishing, 1992; 3-9.
9. Smith R. Introduction. In: Smith A, ed. Audit in ActIon. London: BMJ Publishing,
1992; xii-xiv.
10. Steenkamp HA. Population Estimates for the RSA by Magisterial District and
Province, 1995. Pretoria: Bureau of Market Research, University of South Africa,
1995; 1-73.
11. Central Statistical Services. Mid-year Estimates 1991 - 1995. Pretoria: Central
Statistical Services, 1995; 1-5.
12. Fitzpatrick R. Surveys of patient satisfaction: I - Important general
considerations. In: Smith R. ee1. Audit in Action. I_ondon: BMJ Publishing. 1992;
152-159.
13. Fitzpatrick A. Surveys of patient satisfaction: 11 - Designing a Questionnaire and
conducting a survey. In: Smith A, ed. Audit in Action. London: BMJ Publishing,
1992; 160-167.
14. Maynard A. Economic aspects of cancer care. Eur J Cancer 1993; 29A: suppl 7.
S6-S9.
15. Sitas F. Terblanche M, Madhoo J. Cancer in South Africa, 1990 & 1991.
Johannesburg: South African Institute for Medical Aesearch, 1996; 1-85.
16. Dyer JJ. Comparative cost of mobile and fixed-cliniC primary health care
services. S AIr Med J 1996; 86: 528-530.
17. Mahler AF, Greenwood AM. A simple diabetic clinic information and audIt system.
Diabetic Med 1984; 1: 301-304.
18. Naughton J. Vana JE. The academic health center and the healthy community.
Am J PubliC Health 1994; 84: 1071-1076.
19. Lydeard S. Improvmg outpatient Visits. PractitIoner 1992; 236: 871·875.




M de Groot, G Walther
Objective. To review the indications and accuracy of
diagnostic thoracoscopy for pleural effusions of unknown
origin.
Design. Retrospective review of consecutive patients
referred for diagnostic thoracoscopy over a 5-year period
from 1 January 1989 to 31 December 1993.
Setting. Tertiary referral cardiothoracic unit.
Patients. Thirty-four patients referred from either
medical or oncology services within a university-affiliated
academic complex.
Interventions. All patients had diagnostic thoracoscopy
performed under general anaesthesia. Retrospective data
were collected in respect of presenting symptoms, gross
findings, final pathological findings, amount of drainage,
length of hospital stay and complications of the
procedure. In 7 patients (21 %), iodised talc was insufflated
at the same time to create pleurodesis.
Main results. Final diagnoses were: 17 (50%) malignant
disease, 6 (18%) tuberculosis and 9 (26%) 'negative'
pathology. In 2 (6%), further intervention was required to
make a conclusive diagnosis. The diagnostic sensitivity for
malignant disease was 89% and the specificity 100%. For
pleural tuberculosis both the sensitivity and specificity
were 100%. For 'negative' diagnoses the negative
predictive value was 82%. A history of fever and sweats
had a marked association (P =0.002) with the final
diagnosis of tuberculosis. No association could be
identified between the gross observations at the time of
thoracoscopy and the final diagnosis. The average length
of hospital stay was 6.7 (range 1 - 25) days. There was 1
in-hospital death (3%), and 9 patients (26%) had major
complications related to the procedure.
Conclusions. Diagnostic thoracoscopy is a useful
modality for obtaining a diagnosis in effusions of unknown
origin where other methods have failed. The presence of
symptoms such as fever and sweats is highly associated
with a final diagnosis of tuberculosis.
S Afr Med J 1998; 88: 706-7 1.
Department of Cardiothoracic Surgery, Groote Schuur Hospital and
University of Cape Town
M de GrootMD
G Walther. MO
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Diagnostic thoracoscopy (pleuroscopy) was first introduced
by Jacobaeus in 1910,' when during the era of pulmonary
collapse therapy for tuberculosis it was used to lyse
adhesions, thereby facilitating therapeutic atelectasis. With
the development of more effective treatment for tuberculosis
enthusiasm for and expertise in its use waned. Being
relatively invasive it tended to be shunned by the
pulmonologist and was at the same time viewed by the
surgeon as a minor, unrewarding procedure. The purpose of
this study was to evaluate our local experience with
diagnostic thoracoscopy for patients with pleural effusion
who remain undiagnosed afer preliminary investigations.
Follow-up
Final diagnoses were obtained from pathological reports and
autopsy records or by follow-up notes in cases where no
overt pathological cause was identified. Diagnosis was
considered to be 'negative' if no pathological cause could
be identified or if the patient's eventual course was one of
complete resolution of the EUO. The 'working diagnosis'
was defined as the presumptive clinical diagnosis recorded
by the referral source at the time of admission for the
procedure. Patients with 'negative' pathological findings
were reviewed at 12 or more months after thoracoscopy to
record outcome and confirm diagnostic accuracy.
True negatives + false positives
True positives
Sensitivity = -------------
True positives + false negatives
True negatives
Specificity
Statistical and analytical methods
Categorical differences between groups were analysed using
Pearson's X2 statistic or Fisher's exact test using the SPSS
statistical package (SPSS Inc., Chicago, USA). For




We retrospectively reviewed 34 consecutive diagnostic
thoracoscopies performed for pleural effusion of unknown
origin (EUO) over a 5-year period from January 1989 to
December 1993 in the Department of Cardiothoracic
Surgery at Groote Schuur Hospital. All patients were referred
from either the medical or the oncology services within the
academic complex.
The patient profile and summary of results are shown in
Table I.
Indications for thoracoscopy
For the 34 patients referred with the problem of EUO the
average time from initial medical contact to referral was 25
days (range 1 - 165 days). The most common presenting
symptoms were dyspnoea (76%), chest pain (65%), cough
(62%), significant weight loss (50%) and fever with night
sweats (26%). Fifty-five per cent were current or previous
smokers, 18% had previous exposure to asbestos, and in
11 % there was a history of previous malignant disease.
Final diagnoses
A final diagnosis of malignant disease was made in 17
patients (50%), tuberculosis was found in 6 (18%) and
findings were 'negative' in 11 (32%), of whom 2 (6%) were
eventually found to be falsely negative for malignant
disease. In H,e latter the diagnosis was made by open lung
biopsy in one (lung carcinoma) and lymph node biopsy
(lymphoma) in the other. Comparison of the final diagnosis
with the working diagnosis revealed a change in a high
percentage of cases (fable 11). The most accurate clinical
pre-thoracoscopic diagnosis was with a working diagnosis
of tuberculosis where thoracoscopy confirmed the suspicion
in 85% of cases and the diagnostic specificity was 83%.
However for the remainder, mesothelioma (38%), metastatic
malignancy (45%) and non-malignancy and non-tuberculosis
Procedure description
Thoracoscopy was performed under general anaesthetic in
the main operating suite of the hospital. In 18 cases (53%),
double-lumen endotracheal intubation was used to facilitate
lung collapse and enhance visualisation of the entire pleural
space. In the remainder single-lumen intubation with pleural
venting and low tidal volume ventilation was utilised. In no
patient was CO2 insufflation used. Examination of the pleural
space was enhanced by rolling or tilting the patient to
displace the lung during the procedure.
To choose the optimal site of trocar insertion current chest
radiographs or computed tomography scans were revie"",ed
at the time of the procedure. The patient was positioned in
either a semi-lateral or full lateral decubitus position. After
surgical preparation, needle aspiration was performed at the
site of proposed trocar insertion and specimens were sent
for cytological and bacteriological examination. If the tap
was positive, a 9 mm trocar and sleeve were inserted and
the pleural space evacuated with a standard suction
cannula. The thoracoscope (Karl Stortz GMBH, Germany)
was inserted through the trocar sleeve and the entire pleural
space visualised. Multiple representative biopsies were
taken with optically guided biopsy forceps. Care was taken
to avoid direct lung biopsy or areas where intercostal
arteries or other vessels could be anticipated. At the end of
the procedure an intercostal drain was inserted through the
trocar site into the pleural space and attached to an
underwater drainage system. The drains were left in situ until
less than 50 ml drainage per 24-hour period was observed.
In 7 (21 %) talc insufflation was administered
concomitantly with the thoracoscopy. Two grams of
pharmaceutical grade asbestos-free sterilised iodised tale>
was insufflated into the pleural space using a standard
insufflator (Richard Wolf GMBH, Germany). Complete
coating of the parietes was confirmed visually before




True negatives + false negatives
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" Excluding 2 patients (6%) with a false-negative diagnosis of malignant disease.
Table 11. Final diagnosis compared with presumptive clinical
diagnosis (working diagnosis) as recorded by the referral source
prior to thoracoscopy
Working Final Specificity
diagnosis diagnosis" of clinical
No. (%) No. (%) judgement
Tuberculosis 13 (38) 6 (18) 83%
Mesothelioma 7 (21) 8 (24) 38%
Metastatic 9 (26) 9 (26) 45%
'Negative' 5 (15) 9 (26) 33%
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(33%), the clinical impression was proved wrong in the
majority of cases.
Table III shows the relationship between the final
diagnosis and the pre-operative symptoms and risk factors.
No patient with a final diagnosis of primary or metastatic
tumour had a history of previous malignant disease
(P = 0.014). History of exposure to asbestos was as frequent
in patients found not to have mesothelioma as in those who
did. All patients with a final diagnosis of malignant disease
had a history of smoking. Anorexia and weight loss were
frequently seen with the final diagnosis of tumour or
tuberculosis but was uncommon with a final diagnosis of
'negative' histology.
The gross thoracoscopic findings in each diagnostic
category are displayed in Table IV. There appeared to be no
association between these findings and the final diagnosis.
In the 9 patients with 'negative' diagnoses, 2 were lost to
follow-up, 3 died and in 2 cases autopsy confirmed absence
of malignant disease or active tuberculosis. The remaining 4
patients are alive and well and effusion-free at a mean
follow-up of 24 months.
Diagnostic efficiency
The average time from initial contact by the referring
physician to diagnosis was 28 days (range 1 - 165 days). In
only 1 patient (3%) with pleural tuberculosis could an
appreciable delay in the diagnosis be identified that might
have delayed treatment. Most patients had received pleural
taps and/or closed pleural biopsies as part of their
diagnostic work-up. Of all patients, 71 % had between 1 and
5 aspirations (mean 1.7) and 63% underwent between 1 and
3 closed pleural biopsies (mean 1.4) prior to referral. Four
(12%) were referred without either pleural tap or biopsy, 2
(6%) because of a clinical suspicion of mesothelioma that
was borne out by the final diagnosis.
Thoracoscopy was found to have a sensitivity of 89% and
a specificity of 100% for the diagnosis of malignancy. For
the diagnosis of pleural tuberculosis, both sensitivity and
specificity were 100%. Where the final result of investigation
was 'negative', the negative predictive value was 82%,
confirmed at 1 year after thoracoscopy.
Other therapeutic and operative
procedures
The average amount of pleural fluid drained at the time of
surgery was 1 027 ml (range 0 - 4 000 ml). The average
period of time that the intercostal drains were left in was 58
Table Ill. Relationship between the final diagnosis, risk factors and symptoms
Incidence of risk factor or symptoms (%)
Fever/ Anorexia! Asbestos Malignancy
Final diagnosis sweats weight loss Smoking exposure history
'Negative' 22 11 44 22 22
Mesothelioma 0 63 63t 25 0
Malignant lung 0 40 100t 0 0
Metastatic other 33 75 100t 25 0
Tuberculosis 83" 83 33 33 17
False negative 50 50 50 0 50
" P ; 0.002 - clinical hista<y of fever or night sweats v. a final diagnosis of pleural tuberculosis.
t P ; 0.014 - clinical hlSla<y of smoking v. final diagnosis of malignant disease (all types).
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Table IV. Final diagnosis v. gross observational findings
Final diagnosis
Malignant Metastatic False
Findings No. 'Negative' Mesothelioma lung other Tuberculosis negative
Pleural thickening 13 3 2 2 2 4
Nodules 7 1 2 1 1 1
Nodules and thickening 6 2 3 1




Total 34 9 8 5 4 6 2
Nineteen complications occurred in 16 patients. giving an overall morbidity rate of
47%. One post-procedural death occurred, giving a mortality rate of 3%.
Complications
Complications of the procedures are listed in Table V. The
most common complication was prolonged excessive
drainage, which occurred in 9 (26%). One patient underwent
drainage for over 10 days, before drains could be removed.
Three in this same group developed empyema as a
complication. Of note is that all patients who developed
empyema had talc pleurodesis.
hours (range 2 - 264 hours). In no case was re-expansion
pulmonary oedema documented in the postoperative period.
In addition to the diagnostic procedure, 7 (21 %) had talc
insufflated to stimulate pleurodesis. The indication was
presumed malignant disease in all cases; however, this was
borne out in only 4 of the 7 patients. The clinical results of
this were a complete success in 4, partial success in 2 and
no success in 1, where the lung failed to expand
satisfactorily. Empyema developed in 3, 1 with metastatic
tumour and the other 2 with benign pathological findings.
The median length of stay in hospital after the procedure
was 6.7 days (range 1 - 25 days).
Tumour implantation at the site of trocar insertion
developed in 1 patient with mesothelioma. This was treated
with external-beam radiotherapy and the patient
subsequently survived for 14 months. There was 1 in-
hospital death, a 54-year-old woman with a history of
previous tuberculosis who presented with a large pleural
effusion and diffuse bilateral interstitial lung infiltrates.
Thoracoscopy revealed a generalised pleural thickening and
biopsy was non-diagnostic. Sudden acute respiratory
distress manifested on the second postoperative day and
the patient died shortly thereafter. Autopsy showed
extensive nonspecific pulmonary fibrosis with no evidence of
active tuberculosis or malignancy.
Discussion
The success of cytological analysis of pleural fluid by
thoracentesis varies widely and is reported to be diagnostic
in 45 - 96% of malignant effusions.3.• Where mesothelioma is
the final diagnosis the diagnostic yield is reduced to
approximately 20%.·,7.9 The diagnostic yield is lower with
malignant effusion secondary to primary lung carcinoma
compared with metastatic effusions.'o This may be due to
the fact that effusions may occur as a result of lobar
collapse, lymphatic obstruction, pneumonitis or severe
hypoproteinaemia rather than pleural tumour involvement. A
second tap for cytology can increase the yield by 17 - 22%,
but further aspirations are unlikely to increase this figure. s
For pleural lymphoma the diagnostic yield may be as low as
10%.'0 The false-positive rate of pleural fluid cytology for
malignancy is less than 1% in most series.' The yield from
pleural biopsy alone in malignant effusions has a broad
reported range of success (30 - 70%)."·"0 Prakash tt reported
that in only 7% of patients with non-diagnostic pleural
cytology did an additional closed pleural biopsy give a
finding of malignancy. Storey et a/.'o found a tumour in only 2
of 8 patients (25%) with non-diagnostic cytology.
Conversely, in tuberculous effusions the pleural biopsy often
plays a significant role. Epstein et a/. 12 found closed pleural
biopsy to be diagnostic in 88% of patients, with EUO
subsequently shown to be of tuberculous origin. In a
comprehensive review by Tomlinson and Sahn,· rates of
diagnosis between 60% and 95% are reported. Both non-
diagnostic thoracentesis and pleural biopsy do not ensure
the absence of serious pathology, as was shown in 81 % of
the patients in this study.
The diagnostic yield of most series reviewing basic
diagnostic modalities for pleural effusions ranges from 87%
to 99%.'3 Unfortunately 5 - 27% of patients remain without
diagnosis at the conclusion of normal investigations.'o,,,,,.
With long-term follow-up, approximately 50% of these
patients are found to have malignant disease.· This
percentage varies with the predominant pleural pathology of
the cohort, region and institution.'· In our series, 56% of
patients presenting with EUO were subsequently proven to
have malignant disease. The 18% of our patients
subsequently proven to have tuberculosis is high compared
with most Western series and probably reflects the high
prevalence of this disease within our local community.
Thoracoscopy offers several advantages over repeated
thoracentesis and blind pleural biopsy, viz.: (I) potential
access to the entire pleural space; (il) direct visualisation and
biopsy of pathology; (UI) potential for additional lung biopsy









Prolonged drainage (> 100 ml/day and> 5 days)
Empyema
Incomplete lung expansion
Prolonged air leak (> 3 days)
Respiratory distress
Tumour at insertion site
Death
Table V. Morbidity and mortality
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complications such as bleeding and air leak; and (v) easy
addition of insufflated talc (or other agents) for pleurodesis,
if indicated at the same session.
The reported diagnostic sensitivity for thoracoscopy in
EUO is high. Menzies and Charbonneau· in a prospective
study of 102 patients obtained a definitive diagnosis in 94%
of 95 patients (42 malignant, 31 benigri and 22 idiopathic).
Overall, thoracoscopy was 96% accurate, with sensitivity of
91 %, specificity of 100% and negative predictive value for
pleural malignancy of 100%. These results are comparable
to those of open pleural biopsy,· with the major advantage
being the less invasive nature of the procedure. Publications
from the developed world tend to reflect a high incidence of
malignancy in EUO and correspondingly high success rates
for thoracoscopy,",20 Harris et al.,3 reported a diagnostic
sensitivity of 95 % and specificity of 100% for pleural
malignancy; after a 6-month follow-up they reported a
negative predictive value of 94%. The diagnostic sensitivity
for malignancy in our series was 89% and for pleural
tuberculosis 100%, with specificities of 100% for both. The
negative predictive value for patients not diagnosed with
tumour or tuberculosis was 82%.
In our study we found a poor correlation between gross
thoracoscopic observations and the final diagnosis and
would therefore not recommend that any presumptions be
made on the basis of these findings. Of note is that one
patient described by the operator as having 'gross tumour',
returned the histological diagnosis of tuberculosis. Our
observations did not agree with those of Harris et al.,'3 who
found that age over 50 and a pre-operative history of
malignancy were statistically significant as positive
predictors of malignancy diagnosed at thoracoscopy.
However, our data did show a significant correlation
between a history of fever and sweats and the final
diagnosis of tuberculous effusion. This is similar to the
findings of Marel et al.'· who observed that an elevated
temperature was associated with a non-malignant aetiology
in 73% of cases. A diagnosis of 'negative' histology was
returned in 44% of our patients. Ryan et al." found that 61 %
of patients who underwent a thoracotomy for EUO remained
without a diagnosis during a follow-up of 1.5 - 15 years. In
many of these patients aetiologies such as viral pleurisy or
peri-pneumonic effusion are the probable cause.
It has not been our practice to perform therapeutic
thoracentesis prior to the procedures. The rationale
proposed is to facilitate anaesthesia and prevent re-
expansion pulmonary oedema." No instances of pulmonary
oedema occurred in our series despite amounts of up to 4
litres being removed at a single session. Conversely we feel
that the presence of an effusion facilitates insertion of the
thoracoscopy cannula. The most convincing argument for
pre-operative thoracentesis is that it may demonstrate the
inability of the lung to expand fully, obviating futile attempts
at pleurodesis.3Possibly by utilising this approach the
incomplete lung expansion noted in 2 (6%) of our patients
may have been avoided.
Reported peri-operative mortality rates associated with
diagnostic thoracoscopy range from 0% to 10%.3.2022
Complication rates between 9% and 20% have been
reported"·23 and vary largely because of definition and
completeness of reporting. Our most troublesome
complication was failure of lung expansion (6%), which
contributed to the development of empyema in 1 patient.
One of our patients with mesothelioma developed tumour
implantation at the site of trocar insertion. This has been
reported in approximately 30% of patients with the final
diagnosis of mesothelioma and in 10 - 15% of other tumour
types· This complication is usually adequately palliated with
external beam radiotherapy, as was the case in our patient.
All of our procedures were performed by thoracic
surgeons. Arguably, the simplicity of the procedure allows it
to be used by any practitioner with appropriate training and
equipment. Iatrogenic injuries associated with the procedure
are rare,'''' but it would be prudent to argue for
thoracoscopy to be performed in institutions with amenities
and personnel available for immediate thoracotomy. General
anaesthesia provides optimal analgesia and the option of
one-lung anaesthesia and manipulation to allow visualisation
of the entire free pleural space. Thoracoscopy may be
performed under local anaesthetic with a high degree of
success!' Flexible pleuroscopy has been described925 with
limitations being the availability of equipment and the poor
quality of biopsy material. It can be performed utilising
sterilised standard bronchoscopy equipmenFo Similarly, rigid
thoracoscopy does not necessarily demand specialised
equipment and can be adequately performed using the
standard Carlens mediastinoscope or a rigid
bronchoscope!O
It can be argued that the delay in the diagnosis of a
malignant effusion is immaterial to the final outcome. Harris
et al.,3 found that 48% of patients diagnosed with malignant
disease by thoracoscopy were dead by 6 months. Irani et
al." reported a wide variation in survival depending on site of
origin, the worst being the pancreas with a 3-month
mortality rate of 100% and the best with ovary with a 2-year
survival rate of 20%. In the final analysis the need to press
on to more invasive measures to secure a diagnosis will
depend on: (I) strength of the diagnostic impression; (il) the
patient's anxiety over the diagnosis; and (iil) urgency in
identifying potentially treatable pathology. Harris et a/,3
found that 73% of patients had further surgery or
therapeutic procedures performed, and in 36% the medical
management was affected by the findings. In 10% of
patients the working diagnoses changed as a result of
thoracoscopy.
In conclusion, we feel that diagnostic thoracoscopy is a
useful modality for obtaining a diagnosis in EUO where other
methods have failed. The presence of symptoms of fever
and sweats appears to be associated with a final diagnosis
of tuberculosis and empirical treatment should be
considered.
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A L Christianson, 0 L Viljoen, W S Winship,
M de la Rey, E J van Rensburg
Study objective. To assess clinically South African patients
with the putative diagnosis of Prader-Willi syndrome (PWS)
and confirm this diagnosis by DNA/molecular analysis.
Design. Prospective, nationally based, combined clinical
and laboratory study.
Main results. Thirty-seven patients with a putative
diagnosis of PWS were examined by clinical geneticists.
Only 13 (35.1 %) of these patients had the diagnosis of
PWS confirmed by molecular analysis, and all 13 PWS
patients had positive scores using the PWS consensus
diagnostic criteria of Holm et al. The clinical features of
the remaining 24 (64.9%) non-PWS patients were analysed
and 23 did not have the neonatal, infantile and childhood
features necessary to warrant consideration of a diagnosis
of PWS; neither did they obtain a positive score according
to Holm et al.'s criteria.
Conclusion. PWS was confirmed in only 35% of South
African patients with a putative PWS diagnosis, confirming
that this condition is overdiagnosed and that the clinical
diagnosis is difficult. Clinically, the diagnostic criteria of
Holm et al. are of great assistance in making the
diagnosis, but it remains essential to confirm the diagnosis
by molecular analysis.
S Atr Med J 1998; 88: 711-714.
Prader-Willi syndrome (PWS), first described in 1956,' is a
multisystem disorder characterised by infantile hypotonia,
obesity, hypogonadism, short stature, mild intellectual
disability, behavioural problems, a characteristic facies and
small hands and feet.'-5 Clinical diagnosis of PWS is
considered difficult because many of the features are subtle
or nonspecific, and others change with age. In
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